空间基因组学和转录组学市场—全球产业规模、份额、趋势、机会和预测，按技术、产品类型、应用、最终用户、地区和竞争细分，2020-2030 年

2024年，全球空间基因体学和转录组学市场规模达9.8425亿美元，预计2030年将达到20.141亿美元，预测期内复合年增长率为12.68%。市场成长主要源自于对早期疾病检测和治疗创新日益增长的需求，尤其是在慢性病治疗领域。细胞研究资金的激增以及用于癌症诊断的新型细胞检测方法的开发，进一步推动了市场的发展。此外，空间分析技术的进步——例如NanoString Technologies的GeoMx数位空间分析器（DSP）——扩展了研究能力，尤其是在与Illumina等公司提供的新一代定序平台整合时。

关键市场驱动因素

空间组学的技术进步

主要市场挑战

法规遵从性和验证的复杂性

主要市场趋势

人工智慧与机器学习的融合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球空间基因体学与转录组学市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按技术（空间转录组学与空间基因组学分析）
  • 依产品类型（仪器、耗材、软体）
  • 按应用（转化研究与药物研发）
  • 按最终用户（製药和生物技术公司、合约研究组织、学术和研究机构）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图
• 依技术
• 依产品类型
• 按应用
• 按最终用户
• 按地区

第六章：北美空间基因体学与转录组学市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲空间基因体学与转录组学市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太空间基因体学与转录组学市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美空间基因组学和转录组学市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲太空基因组学和转录组学市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球空间基因组学和转录组学市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• 10X Genomics Inc.
• Akoya Bioscience Ltd.
• Biospyder Technologies Inc.
• BioTechne Corporation
• Dovetail Genomics LLC
• Fluidigm Corporation
• Genomic Vision SA
• Illumina Inc.
• Lunaphore Technologies SA
• Nanostring Technologies Inc

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Spatial Genomics and Transcriptomics Market was valued at USD 984.25 million in 2024 and is anticipated to reach USD 2014.10 million by 2030, growing at a CAGR of 12.68% during the forecast period. The market's growth is primarily driven by increasing demand for early disease detection and therapeutic innovation, particularly in the realm of chronic disease treatment. The surge in funding for cell-based research and the development of novel cell assays for cancer diagnostics is further propelling the market. Additionally, advancements in spatial profiling technologies-like the GeoMx Digital Spatial Profiler (DSP) by NanoString Technologies-have expanded research capabilities, especially when integrated with next-generation sequencing platforms such as those offered by Illumina.

Key Market Drivers

Technological Advancements in Spatial Omics

The rapid technological progress in spatial omics is significantly advancing the spatial genomics and transcriptomics market. High-resolution sequencing and imaging technologies have enabled researchers to map gene expression with spatial precision, enhancing the ability to study biological complexity within tissue samples. Platforms such as the 10x Genomics Visium have exemplified this by merging high-resolution imaging with spatial gene expression data. These innovations have broadened applications across oncology, neuroscience, and developmental biology by supporting the identification of biomarkers, understanding cellular heterogeneity, and enabling the development of targeted treatments. The convergence of spatial data with proteomics and metabolomics continues to enrich biological insight and therapeutic strategies.

Key Market Challenges

Regulatory Compliance and Validation Complexities

A key challenge for the spatial genomics and transcriptomics market lies in the complex and evolving landscape of regulatory compliance and validation. As these technologies integrate sequencing, imaging, and bioinformatics tools, they fall under multiple regulatory jurisdictions, creating ambiguity around standards and approval pathways. Agencies such as the FDA and EMA require rigorous validation for clinical applications, but the novel nature of spatial omics technologies makes it difficult to conform to existing regulatory frameworks. These tools often straddle research and clinical use, complicating standardization around performance metrics such as accuracy and reproducibility. This regulatory uncertainty can slow product approval timelines and hinder broader adoption in clinical settings.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning

Artificial Intelligence (AI) and Machine Learning (ML) are playing a transformative role in the spatial genomics and transcriptomics market. These technologies are increasingly being utilized to manage and analyze the complex, high-volume data generated by spatial omics platforms. AI and ML tools enable enhanced pattern recognition, spatial data inference, and integration with other omics datasets, improving resolution and interpretation. They assist in tasks such as image processing, cell segmentation, and predictive modeling, significantly boosting research accuracy and throughput. This integration is accelerating biomarker discovery, aiding drug development, and enhancing understanding of disease biology, while simultaneously optimizing workflow efficiency and result reproducibility.

Key Market Players

• 10X Genomics Inc.
• Akoya Bioscience Ltd.
• Biospyder Technologies Inc.
• BioTechne Corporation
• Dovetail Genomics LLC
• Fluidigm Corporation
• Genomic Vision SA
• Illumina Inc.
• Lunaphore Technologies SA
• Nanostring Technologies Inc.

Report Scope:

In this report, the Global Spatial Genomics and Transcriptomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spatial Genomics and Transcriptomics Market, By Technique:

• Spatial Transcriptomics
• Spatial Genomics Analysis

Spatial Genomics and Transcriptomics Market, By Product Type:

• Instruments
• Consumables
• Software

Spatial Genomics and Transcriptomics Market, By Application:

• Translational Research
• Drug Discovery & Development

Spatial Genomics and Transcriptomics Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic & Research Institutes

Spatial Genomics and Transcriptomics Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Genomics and Transcriptomics Market.

Available Customizations:

Global Spatial Genomics and Transcriptomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Genomics and Transcriptomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 5.2.2. By Product Type (Instruments, Consumables, Software)
  • 5.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 5.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.6. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Technique
• 5.3.2 By Product Type
• 5.3.3 By Application
• 5.3.4 By End User
• 5.3.5 By Region

6. North America Spatial Genomics and Transcriptomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 6.2.2. By Product Type (Instruments, Consumables, Software)
  • 6.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 6.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Spatial Genomics and Transcriptomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 7.2.2. By Product Type (Instruments, Consumables, Software)
  • 7.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 7.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Spatial Genomics and Transcriptomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 8.2.2. By Product Type (Instruments, Consumables, Software)
  • 8.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 8.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Spatial Genomics and Transcriptomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 9.2.2. By Product Type (Instruments, Consumables, Software)
  • 9.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 9.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Spatial Genomics and Transcriptomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 10.2.2. By Product Type (Instruments, Consumables, Software)
  • 10.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 10.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Spatial Genomics and Transcriptomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 10X Genomics Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Akoya Bioscience Ltd.
• 15.3. Biospyder Technologies Inc.
• 15.4. BioTechne Corporation
• 15.5. Dovetail Genomics LLC
• 15.6. Fluidigm Corporation
• 15.7. Genomic Vision SA
• 15.8. Illumina Inc.
• 15.9. Lunaphore Technologies SA
• 15.10. Nanostring Technologies Inc

16. Strategic Recommendations

17. About Us & Disclaimer